Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

Clinical trial NCT04524442 · COMPLETED

Trial details

NCT number: NCT04524442
Sponsor: Advanced Accelerator Applications
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Gastroenteropancreatic Neuroendocrine Tumors

Start date: 2021-01-25
Primary completion: 2023-11-18
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.